Free Trial
NASDAQ:HUGE

FSD Pharma (HUGE) Stock Price, News & Analysis

$0.35
-0.01 (-2.48%)
(As of 05/24/2024 08:50 PM ET)
Today's Range
$0.34
$0.37
50-Day Range
$0.32
$0.74
52-Week Range
$0.31
$1.68
Volume
197,200 shs
Average Volume
226,194 shs
Market Capitalization
$14.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

FSD Pharma MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of FSD Pharma in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.22) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.59 out of 5 stars

Medical Sector

866th out of 922 stocks

Pharmaceutical Preparations Industry

404th out of 427 stocks

HUGE stock logo

About FSD Pharma Stock (NASDAQ:HUGE)

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

HUGE Stock Price History

HUGE Stock News Headlines

Wall Street Breakfast: Self-Driving Push
Tesla Stock: Plunging Toward My Price Target
HUGE Mar 2024 1.000 call
FSD Pharma Inc.: FSD Pharma Announces US ATM Offering
FSD Pharma Announces US ATM Offering
See More Headlines
Receive HUGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
5/27/2024
Next Earnings (Estimated)
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:HUGE
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Net Income
$-17,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.33 per share

Miscellaneous

Free Float
36,695,000
Market Cap
$14.03 million
Optionable
Optionable
Beta
0.71
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Zeeshan Saeed (Age 54)
    Founder, CEO, President & Executive Co-Chairman
    Comp: $222.62k
  • Mr. Anthony John Durkacz (Age 48)
    Founder & Executive Co-Chairman
    Comp: $222.62k
  • Mr. Nathan Coyle CPA (Age 43)
    Chief Financial Officer
    Comp: $178.21k
  • Mr. Donal Carroll CPA (Age 47)
    Chief Operating Officer
    Comp: $225.62k
  • Dr. Lakshmi P. Kotra BPHARM (Age 53)
    Ph.D., CEO of Lucid & Director
    Comp: $144.72k
  • Ms. Maryann Adesso
    Corporate Secretary
  • Randell Mack
    President of FSD BioSciences
  • Dr. Andrzej Chruscinski M.D.
    Ph.D., Vice President of Clinical & Scientific Affairs of Lucid
  • Mr. Kevin Cassidy
    Vice President of Quality-Lucid

HUGE Stock Analysis - Frequently Asked Questions

How have HUGE shares performed in 2024?

FSD Pharma's stock was trading at $0.9198 at the beginning of 2024. Since then, HUGE stock has decreased by 62.0% and is now trading at $0.3498.
View the best growth stocks for 2024 here
.

When is FSD Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 18th 2024.
View our HUGE earnings forecast
.

How were FSD Pharma's earnings last quarter?

FSD Pharma Inc. (NASDAQ:HUGE) announced its quarterly earnings results on Thursday, March, 28th. The company reported ($0.04) earnings per share (EPS) for the quarter.

What other stocks do shareholders of FSD Pharma own?
How do I buy shares of FSD Pharma?

Shares of HUGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HUGE) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners